Back to results
US 8,575,307 B2Granted
Protein kinase C inhibitors for prevention of insulin resistance and type 2 diabetes
AssigneeHadasit Medical Research Services and Development Ltd.
InventorsEleazar Shafrir, Ehud Ziv, Hadas Reuveni, Masha Niv
Life of this patent
Estimating the term…
Abstract
The present invention provides peptides and peptide analogs capable of inhibiting the activity of protein kinase C. The invention discloses use of such peptides and analogs for preparation of pharmaceutical compositions and methods for prevention, delay, suppression or treatment of type 2 diabetes using such compositions.
Claims5
An isolated peptide comprising the amino acid sequence selected from the group consisting of SEQ ID NO:6 and SEQ ID NO:7.
Dependencies are inferred from the claim text.